Logo image of PHX

PHX MINERALS INC (PHX) Stock Fundamental Analysis

NYSE:PHX - New York Stock Exchange, Inc. - US69291A1007 - Common Stock - Currency: USD

4.14  -0.06 (-1.43%)

Fundamental Rating

5

Overall PHX gets a fundamental rating of 5 out of 10. We evaluated PHX against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While PHX has a great health rating, its profitability is only average at the moment. PHX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PHX was profitable.
PHX had a positive operating cash flow in the past year.
In multiple years PHX reported negative net income over the last 5 years.
PHX had a positive operating cash flow in 4 of the past 5 years.
PHX Yearly Net Income VS EBIT VS OCF VS FCFPHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

PHX has a Return On Assets of 2.90%. This is in the lower half of the industry: PHX underperforms 65.20% of its industry peers.
Looking at the Return On Equity, with a value of 3.82%, PHX is doing worse than 67.65% of the companies in the same industry.
PHX has a worse Return On Invested Capital (2.46%) than 74.51% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHX is significantly below the industry average of 28.75%.
The 3 year average ROIC (11.37%) for PHX is well above the current ROIC(2.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.9%
ROE 3.82%
ROIC 2.46%
ROA(3y)5.48%
ROA(5y)-7.94%
ROE(3y)7.44%
ROE(5y)-13.41%
ROIC(3y)11.37%
ROIC(5y)N/A
PHX Yearly ROA, ROE, ROICPHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

PHX has a Profit Margin of 13.97%. This is comparable to the rest of the industry: PHX outperforms 53.43% of its industry peers.
PHX's Profit Margin has improved in the last couple of years.
PHX's Operating Margin of 14.79% is in line compared to the rest of the industry. PHX outperforms 43.14% of its industry peers.
In the last couple of years the Operating Margin of PHX has grown nicely.
PHX has a better Gross Margin (90.79%) than 95.59% of its industry peers.
In the last couple of years the Gross Margin of PHX has grown nicely.
Industry RankSector Rank
OM 14.79%
PM (TTM) 13.97%
GM 90.79%
OM growth 3YN/A
OM growth 5Y8.7%
PM growth 3YN/A
PM growth 5Y4.79%
GM growth 3Y6.25%
GM growth 5Y5.67%
PHX Yearly Profit, Operating, Gross MarginsPHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PHX is creating some value.
PHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PHX Yearly Shares OutstandingPHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
PHX Yearly Total Debt VS Total AssetsPHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 3.40 indicates that PHX is not in any danger for bankruptcy at the moment.
PHX has a Altman-Z score of 3.40. This is in the better half of the industry: PHX outperforms 79.90% of its industry peers.
The Debt to FCF ratio of PHX is 1.50, which is an excellent value as it means it would take PHX, only 1.50 years of fcf income to pay off all of its debts.
PHX has a Debt to FCF ratio of 1.50. This is amongst the best in the industry. PHX outperforms 80.39% of its industry peers.
PHX has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
PHX has a Debt to Equity ratio of 0.22. This is in the better half of the industry: PHX outperforms 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.5
Altman-Z 3.4
ROIC/WACC0.28
WACC8.74%
PHX Yearly LT Debt VS Equity VS FCFPHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

PHX has a Current Ratio of 3.19. This indicates that PHX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PHX (3.19) is better than 81.37% of its industry peers.
PHX has a Quick Ratio of 3.19. This indicates that PHX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.19, PHX belongs to the top of the industry, outperforming 82.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.19
PHX Yearly Current Assets VS Current LiabilitesPHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

3

3. Growth

3.1 Past

PHX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.14%.
PHX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -47.09% yearly.
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5Y-47.09%
EPS Q2Q%-57.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-33.04%

3.2 Future

Based on estimates for the next years, PHX will show a very strong growth in Earnings Per Share. The EPS will grow by 72.94% on average per year.
Based on estimates for the next years, PHX will show a quite strong growth in Revenue. The Revenue will grow by 12.54% on average per year.
EPS Next Y174.19%
EPS Next 2Y72.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.73%
Revenue Next 2Y12.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
PHX Yearly Revenue VS EstimatesPHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
PHX Yearly EPS VS EstimatesPHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.00, the valuation of PHX can be described as expensive.
71.08% of the companies in the same industry are cheaper than PHX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.63, PHX is valued quite expensively.
PHX is valuated correctly with a Price/Forward Earnings ratio of 16.78.
PHX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of PHX to the average of the S&P500 Index (22.68), we can say PHX is valued slightly cheaper.
Industry RankSector Rank
PE 46
Fwd PE 16.78
PHX Price Earnings VS Forward Price EarningsPHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHX is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHX indicates a somewhat cheap valuation: PHX is cheaper than 74.51% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.39
EV/EBITDA 12.48
PHX Per share dataPHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PHX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHX's earnings are expected to grow with 72.94% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y72.94%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.81%, PHX has a reasonable but not impressive dividend return.
PHX's Dividend Yield is comparable with the industry average which is at 6.67.
PHX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.81%

5.2 History

The dividend of PHX decreases each year by -9.42%.
PHX has been paying a dividend for at least 10 years, so it has a reliable track record.
PHX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-9.42%
Div Incr Years3
Div Non Decr Years3
PHX Yearly Dividends per sharePHX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

PHX pays out 99.28% of its income as dividend. This is not a sustainable payout ratio.
DP99.28%
EPS Next 2Y72.94%
EPS Next 3YN/A
PHX Yearly Income VS Free CF VS DividendPHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M
PHX Dividend Payout.PHX Dividend Payout, showing the Payout Ratio.PHX Dividend Payout.PayoutRetained Earnings

PHX MINERALS INC

NYSE:PHX (2/21/2025, 8:04:00 PM)

4.14

-0.06 (-1.43%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners37.75%
Inst Owner Change-95.64%
Ins Owners16.32%
Ins Owner Change1.54%
Market Cap155.17M
Analysts80
Price Target5.1 (23.19%)
Short Float %0.54%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 3.81%
Yearly Dividend0.1
Dividend Growth(5Y)-9.42%
DP99.28%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)93.87%
Min EPS beat(2)4.85%
Max EPS beat(2)182.89%
EPS beat(4)3
Avg EPS beat(4)39.56%
Min EPS beat(4)-129.41%
Max EPS beat(4)182.89%
EPS beat(8)4
Avg EPS beat(8)0.98%
EPS beat(12)6
Avg EPS beat(12)-23.33%
EPS beat(16)7
Avg EPS beat(16)-52.49%
Revenue beat(2)1
Avg Revenue beat(2)6.93%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)16.3%
Revenue beat(4)2
Avg Revenue beat(4)7.96%
Min Revenue beat(4)-9.29%
Max Revenue beat(4)27.27%
Revenue beat(8)2
Avg Revenue beat(8)-3.75%
Revenue beat(12)6
Avg Revenue beat(12)11.06%
Revenue beat(16)10
Avg Revenue beat(16)20.47%
PT rev (1m)10.7%
PT rev (3m)12.78%
EPS NQ rev (1m)-2.74%
EPS NQ rev (3m)-2.74%
EPS NY rev (1m)-0.66%
EPS NY rev (3m)4.6%
Revenue NQ rev (1m)-5.15%
Revenue NQ rev (3m)-5.15%
Revenue NY rev (1m)-4.57%
Revenue NY rev (3m)-6.87%
Valuation
Industry RankSector Rank
PE 46
Fwd PE 16.78
P/S 4.59
P/FCF 8.39
P/OCF 8.36
P/B 1.26
P/tB 1.26
EV/EBITDA 12.48
EPS(TTM)0.09
EY2.17%
EPS(NY)0.25
Fwd EY5.96%
FCF(TTM)0.49
FCFY11.92%
OCF(TTM)0.5
OCFY11.97%
SpS0.9
BVpS3.3
TBVpS3.3
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 3.82%
ROCE 3.12%
ROIC 2.46%
ROICexc 2.5%
ROICexgc 2.5%
OM 14.79%
PM (TTM) 13.97%
GM 90.79%
FCFM 54.7%
ROA(3y)5.48%
ROA(5y)-7.94%
ROE(3y)7.44%
ROE(5y)-13.41%
ROIC(3y)11.37%
ROIC(5y)N/A
ROICexc(3y)11.62%
ROICexc(5y)N/A
ROICexgc(3y)11.62%
ROICexgc(5y)N/A
ROCE(3y)14.43%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y6.94%
ROICexc growth 3YN/A
ROICexc growth 5Y6.94%
OM growth 3YN/A
OM growth 5Y8.7%
PM growth 3YN/A
PM growth 5Y4.79%
GM growth 3Y6.25%
GM growth 5Y5.67%
F-Score7
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.5
Debt/EBITDA 1.92
Cap/Depr 0.73%
Cap/Sales 0.2%
Interest Coverage 1.79
Cash Conversion 128.53%
Profit Quality 391.46%
Current Ratio 3.19
Quick Ratio 3.19
Altman-Z 3.4
F-Score7
WACC8.74%
ROIC/WACC0.28
Cap/Depr(3y)6.95%
Cap/Depr(5y)8.76%
Cap/Sales(3y)1.19%
Cap/Sales(5y)2.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5Y-47.09%
EPS Q2Q%-57.14%
EPS Next Y174.19%
EPS Next 2Y72.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-33.04%
Revenue Next Year28.73%
Revenue Next 2Y12.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.62%
EBIT growth 3YN/A
EBIT growth 5Y2.69%
EBIT Next Year45.19%
EBIT Next 3Y20.92%
EBIT Next 5YN/A
FCF growth 1Y-56.18%
FCF growth 3Y30.58%
FCF growth 5Y9.21%
OCF growth 1Y-56.03%
OCF growth 3Y29.58%
OCF growth 5Y-2.15%